Valuation: Artivion, Inc.

Market Cap 139.64Cr 121.14Cr 113.58Cr 103.47Cr 194.6Cr 13TCr 197.71Cr 1.34TCr 521.32Cr 6.67TCr 524.26Cr 512.83Cr 22TCr P/E 2026 *
-123x
P/E 2027 * 99.6x
Enterprise Value 139.64Cr 121.14Cr 113.58Cr 103.47Cr 194.6Cr 13TCr 197.71Cr 1.34TCr 521.32Cr 6.67TCr 524.26Cr 512.83Cr 22TCr EV / Sales 2026 *
2.85x
EV / Sales 2027 * 2.57x
Free-Float
89.44%
Yield 2026 *
-
Yield 2027 * -
1 day+0.88%
1 week+6.47%
Current month+6.75%
1 month+18.89%
3 months+20.29%
6 months-28.58%
Current year-37.21%
1 week 26.21
Extreme 26.21
29.34
1 month 22.83
Extreme 22.83
29.34
Current year 19.16
Extreme 19.16
46.84
1 year 19.16
Extreme 19.16
48.25
3 years 12.16
Extreme 12.1582
48.25
5 years 9.64
Extreme 9.64
48.25
10 years 9.64
Extreme 9.64
48.25
Manager TitleAgeSince
Chief Executive Officer 59 02/09/2014
Director of Finance/CFO 53 04/12/2023
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 71 01/12/2003
Director/Board Member 66 01/12/2003
Director/Board Member 61 01/05/2012
Date Insider Type Main position Quantity % Market Cap.
02/06/26 Others

Director

-12,650 0.0261%
02/03/26 Free

Chief Executive Officer

1,34,835 0.2816%
23/02/26 Sell

Compliance Officer

24,832 0.0524%
Change 5-day change 1-year change 3-year change Capi.($)
+0.88%+6.47%-33.33%+69.57% 138.42Cr
+1.08%+5.17%-15.57%+5.32% 19TCr
+0.09%+5.29%-2.14%+8.76% 12TCr
-5.90%+2.58%+8.07%+67.67% 6.37TCr
-0.91%+0.33%+34.28%+58.74% 5.51TCr
+1.20%+7.91%-4.63%-34.97% 4.94TCr
+1.42%+4.44%+16.63%-18.70% 3.38TCr
+1.31%-15.56% - - 3.07TCr
+0.26%+1.01%+46.59%-10.75% 2.47TCr
+0.89%+11.86%-5.01%+19.22% 2.39TCr
Average -0.17%+3.29%+4.99%+18.32% 5.89TCr
Weighted average by Cap. -0.63%+4.04%+0.93%+13.45%

Financials

2026 *2027 *
Net sales 49Cr 43Cr 40Cr 36Cr 68Cr 4.67TCr 69Cr 469.8Cr 183.03Cr 2.34TCr 184.06Cr 180.05Cr 7.81TCr 54Cr 47Cr 44Cr 40Cr 76Cr 5.17TCr 77Cr 520.21Cr 202.67Cr 2.59TCr 203.81Cr 199.37Cr 8.65TCr
Net income -1.01Cr -87.25L -81.8L -74.52L -1.4Cr -96Cr -1.42Cr -9.64Cr -3.75Cr -48Cr -3.78Cr -3.69Cr -160.28Cr 1.61Cr 1.39Cr 1.31Cr 1.19Cr 2.24Cr 153.1Cr 2.27Cr 15Cr 6Cr 77Cr 6.03Cr 5.9Cr 255.97Cr
Net Debt - -
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change Volume
12/26/12 $28.64 +0.88% 7,58,686
11/26/11 $28.39 +7.91% 8,84,609
10/26/10 $26.31 -2.99% 7,28,089
07/26/07 $27.12 +2.07% 10,81,661
06/26/06 $26.57 +1.53% 11,39,504
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
28.39USD
Average target price
42.02USD
Spread / Average Target
+48.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AORT Stock